,i #aaith ,,congress #ast ,session ,h4 ,r4 #fjja ,,in ,,the ,,house ,,of ,,representatives ,november #aj1 #bjbe,mr4 ,crow 7for himself1 ,mr4 ,calvert1 ,ms4 ,sewell1 and ,mr4 ,fitzpatrick7 introduced the following bill2 which was referred to the ,committee on ,veterans' ,affairs ,a ,,bill ,to require the ,secretary of ,veterans ,affairs to submit a report on risk reduction strategies to lower the incidence and prevalence of amyotrophic lateral sclerosis in veterans4 #a4 ,short title ,this ,act may be cited as the ,veterans with ,,als ,reporting ,act4 #b4 ,report on ,amyotrophic ,lateral ,sclerosis in ,veterans 7a7 ,in general ,not later than one year after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs1 in consultation with the ,director of the ,centers for ,disease ,control and ,prevention1 shall submit to ,congress a report on the incidence and prevalence of amyotrophic lateral sclerosis 7commonly known as ,,als74 ,such report shall include-- 7#a7 an assessment of the incidence and prevalence of amyotrophic lateral sclerosis in veterans 7as defined in section #aja of title #ch1 ,united ,states ,code72 7#b7 a description of the resources and support that the the ,centers for ,disease ,control and the ,department of ,veterans ,affairs provides to veterans with amyotrophic lateral sclerosis2 7#c7 a description of any deficiencies in the resources and support described in paragraph 7#b72 7#d7 a strategy to develop and test risk reduction strategies intended to lower the incidence and prevalence of amyotrophic lateral sclerosis among veterans2 7#e7 a strategy to develop a pathway for veterans receiving amyotrophic lateral sclerosis care within ,department of ,veterans ,affairs clinics to participate in clinical trials and research sponsored by the ,department of ,veterans ,affairs2 and 7#f7 any recommendations for the enactment of legislation to address the challenges or needs associated with lowering the incidence and prevalence of amyotrophic lateral sclerosis among veterans4 7b7 ,tracking of amyotrophic lateral sclerosis in members and veterans ,the ,secretary of ,veterans ,affairs shall track the prevalence of amyotrophic lateral sclerosis in veterans using the amyotrophic lateral sclerosis registry and biorepository of the ,centers for ,disease ,control and ,prevention4 7c7 ,subsequent reports ,not later than three years after the date of the enactment of this ,act1 and every three years thereafter1 the ,secretary of ,veterans ,affairs shall submit to ,congress an update to the report required under subsection 7a7 and information on the prevalence of amyotrophic lateral sclerosis tracked under subsection 7b74